← Banking With Billy News

Telomir Pharmaceuticals said a peer-reviewed study supports its epigenetic cancer approach, backing further development of Telomir-Zn. The research cited result

BWB News TV • 2026-08-10 18:56 UTC • By Billy Odell Tucker-Robinson
Telomir Pharmaceuticals said a peer-reviewed study supports its epigenetic cancer approach, backing further development of Telomir-Zn. The research cited result
Telomir Pharmaceuticals said a peer-reviewed study supports its epigenetic cancer approach, backing further development of Telomir-Zn. The research cited results in triple-negative breast cancer and prostate cancer models.
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly